Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
15.02.2017 14:00:00

AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call

ALBANY, N.Y., Feb. 15, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2016 financial results before the opening of the market on Tuesday, February 21, 2017.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET.

The conference call can be accessed by dialing (866) 208-5728 (domestic calls) or (224) 633-1279 (international calls) at 8:20 a.m. ET and entering passcode 61743127. A live webcast with slides will also be available and can be accessed on the company's website at www.amriglobal.com. A replay of the conference call can be accessed for 24 hours at (855) 859-2056 (domestic calls) or (404) 537-3406 (international calls) and entering passcode 61743127. Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at http://ir.amriglobal.com.

About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP), and Fine Chemicals. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-schedules-fourth-quarter-and-full-year-2016-earnings-release-and-conference-call-300407490.html

SOURCE AMRI

Nachrichten zu Albany Molecular Research Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Albany Molecular Research Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!